What are your top takeaways in Gyn Cancers from ASCO 2026?

For ASCO 2026 in the GYN world, from a radiation oncologist's point of view, there was confirmation of immunotherapy benefit in longer-term follow-up of previously reported landmark studies:

1. NRG-GY018 study — adding pembro for advanced measurable endometrial cancer, reported by Eskander et al showe...